Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05505734Phase 3Completed
A Phase 3 trial of salbutamol + budesonide in asthma, sponsored by Bond Avillion 2 Development LP. Started Sep 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05505734.